ANCA-associated Vasculitis - 103 Studies Found
Not yet recruiting |
: Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy : Invasive Pneumococcal Infection : 2017-02-27 :
|
Not yet recruiting |
: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study :
: 2012-04-25 : Other: Observational Observational study of subjects previously enrolled in the RAVE trial |
Active, not recruiting |
: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis :
: 2014-06-19 :
|
Completed |
: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides :
: 2015-06-10 : Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Active, not recruiting |
: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis :
|
Terminated |
: The Clinical Efficacy of DFPP in Patients With AAGN : Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis : 2014-06-03 :
|
Completed |
: MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis :
: 2006-03-10 : Drug: mycophenolate mofetil MMF,1.0g/d Other Name: M |
Withdrawn |
: Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab : Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis : 2010-12-13 :
|
Withdrawn |
: Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens : Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis : 2011-01-10 :
|